Maneesh Singh

Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer

Alexey S. Revenko, Larissa S. Carnevalli, Charles Sinclair et al. · Journal for ImmunoTherapy of Cancer · 2022 · 86 citations · Full text

Medicine, Immunology, Oncology +16

<i>STAT3</i> Antisense Oligonucleotide Remodels the Suppressive Tumor Microenvironment to Enhance Immune Activation in Combination with Anti–PD-L1

Theresa A. Proia, Maneesh Singh, Richard Woessner et al. · Clinical Cancer Research · 2020 · 53 citations · Full text

Medicine, Immunology, Oncology +17

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer

Seock‐Ah Im, Alessandra Gennari, Y.H. Park et al. · ESMO Open · 2023 · 52 citations · Full text

Medicine, Oncology, Breast Oncology +14

PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors

Anna D. Staniszewska, Joshua Armenia, Matthew King et al. · OncoImmunology · 2022 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

DUSP3 Genetic Deletion Confers M2-like Macrophage–Dependent Tolerance to Septic Shock

Pratibha Singh, Lien Dejager, Mathieu Amand et al. · The Journal of Immunology · 2015 · 44 citations · Full text

Life Sciences, Immunology, Physiology +17